Finance

Boost to medical tourism, PPPs, exemption of customs duties on life-saving medicines, increase in medical seats cheered by…

Bone regeneration fuels 4 per cent CAGR growth in South Korea's market through 2033

FDA approvals and competitive launches drive significant growth in the pulsed field ablation market

The Australian oncology devices market is set to grow by 3% CAGR through 2033, driven by rising cancer cases, government…

As myopia rates rise, China's intraocular lens market is poised for growth, driven by the need for long-term, effective vision…

Early-stage investments dominate as sector funding reaches $69.8 million, led by deals from 3Gen Consulting, Laurus Bio, and…

To date, AHH has invested approximately US$300 million across hospital chains in Oncology, Mother & Childcare, Urology &…

As per Tracxn.com, funding dips to $4.02 million in November 2024 from $73.4 million in October 2024

The all-cash transaction imparts 100 per cent ownership of the target company from 87 per cent previously

With the recently raised funding, the company aims to commercialise nanorobotics-based medical devices, initially targeting dental…